Allogeneic bone marrow transplantation in Fanconi anemia

Bone Marrow Transplantation

Volumn 18, Issue SUPPL. 3, 1996, Pages

  Gluckman, E ^a  

^a SAINT LOUIS HOSPITAL   (France)

Author keywords

Allogeneic bone marrow transplantation; Fanconi anemia

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; THIOTEPA;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOSOMAL RECESSIVE INHERITANCE; BLOOD TRANSFUSION; CHROMOSOME 9; CONFERENCE PAPER; DRUG TOXICITY; FANCONI ANEMIA; GENE THERAPY; GRAFT VERSUS HOST REACTION; HLA MATCHING; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; METASTASIS; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; SIBLING;

BONE MARROW TRANSPLANTATION; FANCONI ANEMIA; GENE THERAPY; HISTOCOMPATIBILITY; NUCLEAR FAMILY; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TRANSPLANTATION CONDITIONING; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030476037     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (30)

1. Auerbach AD, Rogatko A, Schroeder-Kurth TM. International Fanconi anemia registry: relation of clinical symptoms to diepoxybutane sensitivity. Blood 1989; 73: 391-396.
2. Auerbach AD, Woman SR. Susceptibility of Fanconi anemia fibroblasts to chromosome damage by carcinogens. Nature 1976; 261: 494-496.
3. Berger R, Bernheim A, Gluckman E. In vitro effect of cyclophosphamide metabolites on chromosomes of Fanconi's anaemia patients. Br J Haematol 1980; 45: 565-568.
4. Strathdee CA, Duncan AMV, Buchwald M. Evidence for at least four Fanconi anaemia genes including FACC on chromosome nine. Nat Genet 1992; 1: 196-198.
5. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature 1992; 356: 763-767.
6. Yamashita T, Barber DL, Zhu Y et al. The Fanconi anemia polypeptide FACC is localised to the cytoplasm. Proc Natl Acad Sci USA 1994; 91: 6712-6716.
7. Walsh CE, Nienhuis AW, Samulski RJ et al Phenotypic correction of Fanconi anemia in human hematopoietic cells with a recombinant adeno-associated virus vector. J Clin Invest 1994; 94: 1440-1448.
8. Segal GM, Magenis RE, Brown M et al. Repression of Fanconi anemia gene (FACC) expression inhibits growth of hematopoietic progenitor cells. J Clin Invest 1994; 94: 846-852.
9. Butturini A, Gale RP, Verlander PC et al. Hematological abnormalities in Fanconi anemia: an international Fanconi anemia registry study. Blood 1994; 84: 1650-1655.
10. Auerbach AD, Allen RG. Leukemia and preleukemia in Fanconi anemia patients. Cancer Genet Cytogenet 1991; 51: 1-12.
11. Stark R, Thierry D, Richard P, Gluckman E. Long-term bone marrow culture in Fanconi's anaemia. Br J Haematol 1993; 83: 554-559.
12. Stark R, Andre C, Thierry D et al. The expression of cytokine and cytokine receptor genes in long-term bone marrow culture in congenital and acquired bone marrow hypoplasias. Br J Haematol 1993; 83: 560-566.
13. Rosselli F, Sanceau J, Gluckman E et al. Abnormal lymphokine production a novel feature of the genetic disease Fanconi anemia: II. In vitro and in vivo spontaneous overproduction of tumor necrosis factor alfa. Blood 1994; 83: 1216-1225.
14. Guinan EC, Lopez KD, Huhn RD et al. Evaluation of granulocyte-macrophage colony-stimulating factor for treatment of cytopenia in children with Fanconi anemia. J Pediatr 1994; 124: 144-150.
15. Gluckman E, Devergie A, Schaison G et al. Bone marrow transplantation in Fanconi anemia. Br J Haematol 1980; 45: 557-564.
16. Dutreix J, Gluckman E. Skin test of radiosensitivity. Application to Fanconi anemia. J Eur Radiother 1983; 4: 3-8.
17. Gluckman E, Devergie A, Dutreix J. Radiosensitivity in Fanconi anemia: application to the conditioning for bone marrow transplantation. Br J Haematol 1983; 54: 431-440.
18. Gluckman E. Bone marrow transplantation for Fanconi anemia. Baillière's Clin Haematol 1989; 2: 153-162.
19. Socie G, Gluckman E, Raynal B et al. Bone marrow transplantation for Fanconi anemia using low dose cyclophosphamide/thoraco-abdominal irradiation as conditioning regimen: chimerism study by the polymerase chain reaction. Blood 1993; 82: 2249-2256.
20. Gluckman E, Auerbach AD, Horowitz M. Bone marrow transplants for Fanconi anemia. International bone marrow transplant registry. Exp Hematol 1990; 20: 831 (Abstr).
21. Hows JM, Chapple M, Marsch JCW et al. Bone marrow transplantation for Fanconi anaemia: the Hammersmith experience 1977-1989. Bone Marrow Transplant 1989; 4: 629-634.
22. Kohli-Kumar M, Morris C, Delaat C et al. Bone marrow transplantation in Fanconi anemia using matched sibling donors. Blood 1994; 84: 2050-2054.
23. Flowers MED, Doney KC, Storb R et al. Marrow transplantation for Fanconi anemia with or without leukemic transformation: an update of the Seattle experience. Bone Marrow Transplant 1992; 9: 167-173.
24. Zanis-Neto J, Ribeiro RC, Meideros C et al. Bone marrow transplantation for patients with Fanconi anemia: a study of 24 cases from a single institution. Bone Marrow Transplant 1995; 15: 293-298.
25. Socie G, Henry-Amar M, Cosset JM et al. Increased incidence of solid malignant tumors after bone marrow transplantation for severe aplastic anemia. Blood 1991; 78: 277-279.
26. Deeg HJ, Socie G, Schoch G et al. Malignancies after marrow transplantation for aplastic anemia and Fanconi anemia: a joint Seattle and Paris analysis of results in 700 patients. Blood 1996; 87: 386-392.
27. Gluckman E, Joenje HJ. Fanconi anemia research: current status and prospects. Eur J Cancer 1995; 31A: 268-272.
28. Gluckman E, Auerbach AD, Horowitz MM et al. Bone marrow transplantation in Fanconi anemia from the International Bone Marrow Transplant Registry. Blood 1995; 86: 2856-2862.
29. Gluckman E, Broxmeyer HE, Auerbach AD et al. Hematopoietic reconstitution in a patient with Fanconi anemia by means of umbilical cord blood from HLA identical sibling. New Engl J Med 1989; 321: 1174-1178.
30. Liu JM, Buchwald M, Walsh CE, Young NS. Fanconi anemia and novel strategies for therapy. Blood 1994; 84: 3995-4007.